Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in Baxter International Inc. $BAX

Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Baxter International Inc. (NYSE:BAX) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 659,668 shares of the medical instruments supplier’s stock, valued at approximately $14,064,000. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.13% of Baxter International as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in BAX. Covestor Ltd grew its stake in shares of Baxter International by 9.5% during the fourth quarter. Covestor Ltd now owns 8,014 shares of the medical instruments supplier’s stock valued at $153,000 after buying an additional 695 shares during the last quarter. Bruce G. Allen Investments LLC increased its holdings in shares of Baxter International by 22.8% in the fourth quarter. Bruce G. Allen Investments LLC now owns 4,452 shares of the medical instruments supplier’s stock worth $85,000 after buying an additional 827 shares during the period. Jump Financial LLC lifted its stake in shares of Baxter International by 5.7% in the 4th quarter. Jump Financial LLC now owns 15,968 shares of the medical instruments supplier’s stock valued at $305,000 after acquiring an additional 854 shares during the last quarter. Nicholas Hoffman & Company LLC. lifted its stake in shares of Baxter International by 2.1% in the 4th quarter. Nicholas Hoffman & Company LLC. now owns 46,913 shares of the medical instruments supplier’s stock valued at $897,000 after acquiring an additional 943 shares during the last quarter. Finally, LRI Investments LLC boosted its holdings in Baxter International by 48.2% during the 4th quarter. LRI Investments LLC now owns 3,006 shares of the medical instruments supplier’s stock valued at $57,000 after acquiring an additional 978 shares during the period. 90.19% of the stock is owned by institutional investors.

Baxter International Trading Down 1.0%

BAX opened at $26.37 on Friday. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32. The business has a 50 day simple moving average of $23.51 and a two-hundred day simple moving average of $20.32. The firm has a market capitalization of $13.63 billion, a price-to-earnings ratio of -12.74, a PEG ratio of 4.03 and a beta of 0.60.

Baxter International (NYSE:BAX) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.The firm had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. During the same period last year, the company earned $0.59 EPS. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Analysts predict that Baxter International Inc. will post 2.04 EPS for the current year.

Baxter International Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, August 28th will be issued a $0.01 dividend. The ex-dividend date is Friday, August 28th. This represents a $0.04 annualized dividend and a yield of 0.2%. Baxter International’s payout ratio is -1.93%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on BAX. Barclays lifted their price target on Baxter International from $25.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday, May 1st. Wells Fargo & Company increased their price objective on Baxter International from $19.00 to $23.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Wall Street Zen upgraded shares of Baxter International from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. TD Cowen lifted their target price on shares of Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research note on Monday, July 27th. Finally, The Goldman Sachs Group upped their price target on shares of Baxter International from $19.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, July 15th. Two research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Baxter International presently has a consensus rating of “Hold” and an average target price of $22.45.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.